Cox regression and survival analysis from the tauro-urso-deoxycholic trial in amyotrophic lateral sclerosis

Recent phase II pilot clinical trials suggested that tauro-urso-deoxycholic acid (TUDCA) might slow functional decline and increase survival in patients with amyotrophic lateral sclerosis (ALS). We performed a multivariate analysis of the original TUDCA cohort to better define the treatment effect a...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Frontiers in Neurology
المؤلفون الرئيسيون:	Giorgio Reggiardo, Maria Lo Giudice, Stefania Lalli, Gilberto Rinaldi, Alberto Albanese
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Frontiers Media S.A. 2023-04-01
الموضوعات:	amyotrophic lateral sclerosis tauro-urso-deoxycholic acid bile acids disease modification survival
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fneur.2023.1163855/full